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Various exogenous stimuli, e.g., rubbing, pressure,
cold, heat, or electromagnetic waves, have been
described to elicit whealing reactions, the so-called
physical urticarias. They may occur as isolated dis-
eases or in association with other types of urticaria.
In many cases, the respective physical factors can be
de®ned exactly, e.g., the degree of temperature
changes or the range of eliciting ultraviolet wave-
lengths. In contrast, the underlying pathomechan-
isms are mostly still obscure. In the past, often
contradictory results have been reported regarding
the role of IgE, complement factors, histamine, or
even mast cells. Recently, many investigations have
been performed on solar urticaria where subgroups
of patients with different clinical and pathophysiolo-
gic features could be de®ned and mechanisms of tol-
erance induction have been studied that also offered
an ef®cient treatment modality. Therefore this
review will mainly focus on this type of disease as a
paradigm of the pathomechanisms of physical
urticaria. Key words: mast cells/photoallergen/solar urti-
caria/tolerance. Journal of Investigative Dermatology
Symposium Proceedings 6:135±136, 2001
T
he physical urticarias form a heterogeneous group of
diseases due to the wide range of eliciting stimuli or
clinical pictures as well as their association with other
types of urticaria. Dermographic, cold, and pressure
urticaria often occur together with chronic idiopathic,
cholinergic, or other physical urticarias. In contrast, solar or heat
urticaria mostly appear either as isolated diseases or are associated
only with other types of physical urticaria (Henz, 1989). This
suggests that in the former types nonspeci®c mechanisms play a
role, e.g., a lowered threshold of mast cell activation or higher
reactivity of target cells. This has been observed in patients with
dermographic urticaria, who may also suffer from bronchial
hyperreactivity to histamine or metacholine. In contrast, more
speci®c mechanisms may be important in solar and heat urticaria;
however, many questions concerning the pathomechanisms of
physical urticarias remain to be clari®ed: How is a physical stimulus
transformed to the level of molecular and cellular activation? Do
IgE molecules and mast cells play a decisive role? Which mediators
derived from mast cells or other sources are responsible for the
activation of endothial cells, dermal nerve endings, and the in¯ux of
in¯ammatory cells? What is the role of this in¯ammatory in®ltrate?
In the past, many functional and biochemical studies led to
inconsistent or even contradictory results. All these data on the
different types of physical urticaria cannot be discussed in detail
here, therefore I will focus on the pathomechanisms of solar
urticaria, as many interesting investigations have been performed
recently.
PHOTOALLERGENS
In about 75% of patients from a large survey reported by Japanese
authors, photosensitive activity could be observed in the serum that
produced a wheal and ¯are reaction upon intradermal injection
following in vitro irradiation using individual eliciting wavelengths
(Uetsu et al, 2000). The fact that irradiated patient serum injected
into the skin of healthy recipients fails to produce such a reaction
argues against a phototoxic mechanism in solar urticaria. The origin
of the postulated circulating photoallergen is still unclear. Blocking
the arterial blood supply prevented an urticarial reaction upon
irradiation in some patients, suggesting an extracutaneous produc-
tion of a photoallergen (Ramsay et al, 1970). Leenutaphong et al
(1989), however, reported a patient who failed to respond to
injection of his irradiated serum, but reacted to eluates from in vivo
irradiated skin or irradiated eluates from the epidermis. In addition,
stripping off of the horny layer or removal of the suction blister roof
abolished urticarial reactions upon irradiation. From this, it may be
concluded that in some patients a photoreactive precursor molecule
is produced in the epidermis and forms a photoallergen upon
activation by UV or visible light. Few attempts have so far been
made to characterize the circulating photoallergen. A 25±45 kDa
molecule that displayed wheal and ¯are activity could be demon-
strated in patients with an action spectrum between 400 and
500 nm. In one case, reactivity to UVA and short-wave visible
light from 330 to 520 nm was associated with an additional high
molecular weight activity of 300±1000 kDa, and in patients
showing a broad spectrum of activity from UVB to visible light
multiple photoallergens seemed to be present (Kojima et al, 1986).
This relationship between the individual action spectrum and the
nature of the photoallergen is also interesting with regard to the
different action spectra prevailing in different groups of patients:
among 24 Belgium patients, most reacted to UVA alone or to UVA
together with UVB or visible light (Ryckaert and Roelandts,
1998). In a series of 40 Japanese patients the majority (n = 24) was
only responsive to visible light. This indicates that the nature of the
responsible photoallergen may be dependent on either racial or
enviromental factors.
Among patients with solar urticaria, two groups (types I and II)
could be classi®ed based on their skin reaction to in vitro irradiated
serum (Leenutaphong et al, 1989). Type I patients only responded to
their own serum, in the type II group a reaction also developed with
irradiated serum from normal subjects. Therefore, in the ®rst group,
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an abnormal photoreactive factor seems to be produced that can lead
to an allergic reaction, but in the type II patients a physiologic
precursor molecule forms an allergen upon activation by irradiation.
As a consequence, passive transfer experiments, i.e., injection of
patient serum in healthy recipients and subsequent irradiation, will
only occasionally give positive results with type I serum if speci®c
IgE as well as the abnormal precursor molecule are transferred. In
contrast, type II serum transfer usually gives a positive reaction as the
photoreactive precursor is also produced by normal subjects. Type I
patients are mostly responsive to visible light, whereas no predom-
inant action spectrum is observed in the type II patients, further
indicating molecular heterogeneity of photoallergens. Due to ethical
reasons investigations based on injection of foreign sera are dif®cult
to perform, but in vitro histamine release from blood basophils may
replace such in vivo tests. For example, we could observe marked
histamine release in a patient with extreme sensitivity to UVA and
UVB by stimulation with his own and also normal irradiated serum.
Nonirradiated serum from neither the patient nor healthy controls
showed this activity. Accordingly, the patient could be assigned to
the type II group.
IGE, MAST CELLS, AND INFLAMMATION
A pathophysiologic role of IgE in physical urticaria is mainly
inferred from passive transfer experiments, but de®nite proof is still
lacking. Positive results in demographic urticaria have been
doubted, whereas cold and solar urticaria reactions could be
reproduced. The role of mast cells in the pathogenesis of solar
urticaria has also to be clari®ed: an increase of histamine in the
ef¯uent blood after local irradiation has been observed together
with histologic signs of mast cell degranulation in lesional skin
(Keahey et al, 1984). Induction of unresponsiveness by repeated
injection of histamine liberators like polymyxin B, however, did
not prevent a urticarial response to irradiation in all patients
(Torinuki et al, 1983). In addition, antihistamines often produce an
unsatisfactory clinical effect. Interestingly, in cases of heat, cold, and
solar urticaria terfenadine may suppress whealing and itch, whereas
the development of erythema still occurs (Cox et al, 1989). These
observations correspond with data from a sequential ultrastructural
analysis in solar urticaria: within 3 min of UV irradiation, when
only erythema had developed, signs of increased endothelial
permeability, platelet activation, and swelling of nerve ®bers
could be observed. Only 10 min later, mast cell degranulation
and accumulation of eosinophils accompanied cutaneous whealing.
Thus non mast cell dependant mechanisms may be involved in the
early phases of solar urticaria. At the time of 4 h, erythema and
whealing had almost disappeared, but signs of mast cell degranula-
tion were still present together with the extravasation of eosinophils
and neutrophils (Leenutaphong et al, 1990). This in¯ux of in¯am-
matory cells has been investigated in detail by Norris et al (1988):
in®ltration by neutrophils and eosinophils peaked at approximately
2 h and mononuclear cells were only observed after high
concentrations of UV irradiation with a delay of up to 24 h. The
fact that leukocyte in¯ux is prominent when clinical signs have
almost disappeared may suggest a downregulatory effect possibly by
degradation of mast cell mediators.
INHIBITION SPECTRUM AND INDUCTION OF
TOLERANCE
A unique feature of solar urticaria is the so-called inhibition
spectrum that has been particularly reported from Japanese patients:
in most cases exposure to wavelengths longer than the action
spectrum immediately after active irradiation suppresses the
urticarial response that only develops after cessation of the
inhibitory irradiation (Watanabe et al, 1999). Applying the inhib-
ition spectrum beforehand or irradiation with shorter wavelengths
is mostly ineffective. This temporary suppression of the urticarial
response corresponds to a delayed plasma histamine peak. The
underlying mechanisms of the inhibition spectrum are still unclear:
the destruction of the allergen precursor is unlikely as the inhibition
spectrum usually only works if it is applied after the action
spectrum. Even by prolongation of the inhibition spectrum,
whealing of the skin cannot be fully suppressed, but is only
delayed. This argues against a reconversion of the photoallergen
into the inactive precursor. A more probable explanation is a
temporary blockade of allergen binding leading to inhibition of
mast cell degranulation (Horio et al, 1984).
The phenomenon of inhibitory spectrum must not be confused
with clinical tolerance, which can be achieved in solar and other
types of physical urticaria by repeated exposure to sub- or over-
threshold stimuli; however, in cold urticaria maintenance of
unresponsiveness by daily bathing or showering with cold water
is often dif®cult. UV treatment in solar urticaria is used more
frequently. It is not always necessary to apply the respective active
wavelengths, i.e., UVB treatment can be used for patients who
react to UVA or visible light. Epidermal thickening and pigmen-
tation may partially explain the induction of tolerance. But this
does not account for the rapid effect within a few hours of using
UVA (Beissert et al, 2000). Depletion of mast cell mediators by
repeated stimulation may be considered as a relevant mechanism.
This is, however, incompatible with the observation that mast cell
degranulation could not be observed by electron microscopy
during the induction of tolerance. In addition, erythema and wheals
following the intradermal injection of mast cell degranulators were
similar before and after induction of tolerance (Keahey et al, 1984).
Furthermore, cutaneous tachyphylaxis to histamine seems unlikely
as the response to histamine injection was not altered after tolerance
induction. General exhaustion of the photoallergen or the precur-
sor molecule by repeated irradiation can be excluded by the fact
that solar urticaria can still be evoced in areas shielded during
tolerance induction. The occupation of allergen binding sites on
cutaneous mast cells by repeated irradiation may account for the
tolerance phenomenon (Leenutaphong et al, 1990). Additionally
speci®c inhibition of intracellular IgE-dependent signaling in mast
cells is discussed, whereas other mast cell activators such as codein
and polymyxin B are still active.
Although different therapeutic approaches are described for
physical urticarias, an effective treatment often remains a challen-
ging task for the physician. A better understanding of relevant
pathomechanisms should help us to obtain more satisfying thera-
peutic results.
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